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Abstract:   
Considerable evidence from epidemiological and clinical studies demonstrated that maternal 
nutritional status is closely associated with placental, embryonic, fetal growth and development, 
and ultimately pregnancy outcomes. In recent years, there has been a growing interest in the 
study of disorders of pregnancy using a metabolomic profiling approach. In this study, we 
presented an integrated comprehensive profiling approach to assess maternal nutritional status 
through measuring a wide variety of small-molecule metabolites and trace elements in serum of 
pregnant women. A total of 56 pregnant women with normal pregnancy outcomes were enrolled 
from Lvliang prefecture of Shanxi province, the area with the highest prevalence of congenital 
anomalies in China, and 40 pregnant women with normal pregnancies were recruited from 
Huairou county of Beijing city, the region representing a national average level. As compared 
with the national average level, these pregnant women from Lvliang region shown distinct 
metabolic phenotypic variations as revealed by the depleted serum concentrations of folate and 
vitamin B12, lower concentrations of carbohydrates, lipids, Se, Zn, and Cu, as well as higher 
concentrations of amino acids, urea-cycle metabolites, Sr, Cd, and Pb. Our results offer an 
improved understanding of severe multifaceted malnutrition in the pregnant women from a 
population with a high prevalence of congenital anomalies, highlighting the potential of a panel 
of critical nutrients as markers for aiding the diagnosis, prevention, and intervention of 
pregnancy complications.  
 
Article: 
INTRODUCTION 
Emerging evidence from epidemiological and clinical studies demonstrates that maternal 
malnutrition during pregnancy can be detrimental to embryonic and fetal development because 
maternal environment alters the epigenetic state of the fetal genome through cell signaling 
occurred in the placenta (Zhang et al. 2008; Martin-Gronert and Ozanne 2006; Wu et al. 2004; 
Harding 1999). Failure to supply sufficient amount of nutrients mandatory for embryonic and 
fetal development before and during pregnancy will result in a suboptimal intra-uterine 
environment for embryonic and fetal growth and development (Keen et al. 2003; Harding and 
Johnston 1995). The immediate response of a fetus to undernourishment is, through utilizing 
alternative energy supply or altering its own metabolic rate, to adapt itself to maximize the 
opportunity for postnatal survival (Martin-Gronert and Ozanne 2006; Harding and Johnston 
1995). The adaptation of a fetus during fetal development, unfortunately, increases the risk of 
permanent changes in fetal structure or body function e.g., congenital anomalies (Forchielli et al. 
1994).  
 
Congenital anomalies are severe physical malformations, deformations, and chromosomal 
abnormalities (Q00–Q99, codes of the International Classification of Diseases) that are present at 
birth (Christianson et al. 2006). Congenital anomalies affect one in every 33 babies born in the 
United States annually (Rynn et al. 2008) and approximately 7.9 million infants in the world (6% 
of worldwide births) (Christianson et al. 2006). Congenital anomalies are also a leading cause of 
infant deaths, accounting for over 20% of all infant deaths in the United States (Martin et al. 
2008). The birth prevalence of congenital malformations in the Chinese population varies 
because of regional differences in socioeconomic status, dietary habits, lifestyles,environmental 
factors, and medical care etc. (Berry et al. 1999; Li et al. 2009; Zhang et al. 2008; Zheng et al. 
2007). For instance, the prevalence of congenital malformations in Beijing city, the capital of the 
People’s Republic of China, is 175.6/10,000 (Li et al. 2009), whereas our recent epidemiological 
investigation reported that the prevalence of congenital malformations in a rural area—Lvliang 
preference of Shanxi province is approximately 844.2/10,000, which is among the highest in the 
world (Zheng et al. 2007).  
 
For decades, remarkable progress has been made to prevent and improve disorders of pregnancy 
such as intrauterine growth restriction (IUGR), small for gestational age (SGA) or large for 
gestational age (LGA), stillbirth, congenital anomalies and so forth through regulating maternal 
nutritional status (CDC 1992; Berry et al. 1999; De Wals et al. 2007; King 2006). It has been 
suggested that vitamin D supplementation has beneficial effect on preeclampsia, SGA risk, birth 
weight, and postnatal growth, however, the clinical effect of dietary vitamin D supplementation 
during pregnancy has not been fully evaluated by more rigorous and well-designed randomized 
clinical trials (Brannon and Picciano 2011; Leffelaar et al. 2010; Robinson et al. 2011). Food 
fortification with folic acid significantly reduces the risk of neural tube defects (NTDs), one of 
the most common congenital malformations, in the pregnant women (CDC 1992; Berry et al. 
1999; De Wals et al. 2007). Nevertheless, maternal folate deficiency is not necessarily the sole 
recognized risk factor for NTDs occurrence because DNA methylation relies on not only 
cofactors such as folic acid, vitamin B3, and B12, but also dietary methyl donors including 
glycine, choline, and serine in biological system (Koury and Ponka 2004; Mosley et al. 2009; 
Steegers-Theunissen 1995; Zeisel and da Costa 2009; Zhu et al. 2009). Accumulating evidence 
supports that dietary vitamin C, alone or in combination with vitamin E, during pregnancy does 
not reduce the risk of preeclampsia, early pregnancy failure, fetal loss, and SGA infant 
(Klemmensen et al. 2009; McCance et al. 2010; Polyzos et al. 2007). With increasing awareness 
of the importance and challenge of embryonic and fetal development, it is becoming evident and 
crucial to assess overall maternal nutritional status such that the underlying association of 
maternal nutrition with the potential risk for pregnancy complications could be uncovered.  
 
To date, ultrasonography has been extensively used in obstetrics and gynecology to examine 
embryos or fetuses during routine prenatal care as this technique allows clinicians and prenatal 
specialists to monitor health status of a fetus and to diagnose potential pregnancy complications 
at an early gestation stage (ACOG Practice Bulletin No. 58. Ultrasonography in pregnancy 2004; 
McIntire et al. 1999). In clinical practice, however, screening ultrasonography does not improve 
pregnancy outcomes in terms of two key metrics i.e., the increased number of live births and the 
reduced number of perinatal morbidity (Crane et al. 1994; Ewigman et al. 1993; Bucher and 
Schmidt 1993). One possible explanation of this phenomenon is that once a fetus is diagnosed as 
phenotypic or physical anomalies using ultrasonography, the homeostatic state of the epigenetic 
networks and their interactive surroundings including gene expression, proteins, and small-
molecule metabolites present in biological system have been disrupted substantially and can no 
longer be retrieved to the normal physiological condition (Zhu et al. 2009; Martin-Gronert and 
Ozanne 2006; Gallou-Kabani and Junien 2005). Thus, it is of imperative importance to develop 
guidelines and protocols that can assist clinicians and physicians in early diagnosis and 
management of pregnant subjects with abnormal pregnancy outcomes.  
 
Metabolomics/metabonomics has been rapidly evolved and become a robust and powerful tool 
that is capable of quantitatively assessing the dynamic multi-parametric metabolic response of 
living systems to pathophysiological stimuli or genetic modification through simultaneously 
measuring a set of metabolic end-point small-molecule metabolites (metabolome) in biological 
matrices (Fiehn 2002; Nicholson et al. 1999). As metabolome is closest to phenotype of the 
specific biological system, there is a growing research interest in using 
metabolomics/metabonomics approach to study pregnancy complications. Metabolic profiling of 
amniotic fluid from a rat model of maternal diet restriction to mimic famine condition 
demonstrated a close association of prenatal malnutrition with abnormal fetal neurodevelopment 
(Shen et al. 2008). Studies employing mass spectrometry-based metabolomics observed 
metabolic profile changes in placental explants cultured under different oxygen tensions (Dunn 
et al. 2009; Heazell et al. 2008). Horgan et al. applied metabolomic technology to investigate the 
differences between small for gestational age (SGA) and normal pregnancies under different 
oxygen conditions (Horgan et al. 2010). Tissot van Patot et al. demonstrated metabolic 
differences in placental tissue from pregnancies at low and high altitude using nuclear magnetic 
resonance (NMR)-based metabolomics strategy (Tissot van Patot et al. 2010). Metabolomics has 
also been used to differentiate women suffering from preeclampsia and those with normal 
pregnancies (Kenny et al. 2010; Odibo et al. 2011; Turner et al. 2007). We have recently 
reported that metabolic signature of pregnant women with neural tube defects (NTDs) in 
offspring can be characterized by the impaired mitochondrial respiration, neurotransmitter γ-
aminobutyric acid, and methionine cycle (Zheng et al. 2011), which was supported by metabolic 
profile changes in a mouse model of di-n-butyl phthalate (DBP)-induced teratogenesis (Xia et al. 
2011).  
 
As reported in our previous epidemiological surveillance and investigation, insufficient intake of 
vegetables, fruits, meat, milk, and certain micronutrients including folic acid, zinc, and selenium 
in pregnant women from Lvliang preference of Shanxi province may be the key diet factor for 
high prevalence of congenital anomalies in this area (Zhang et al. 2008). The ultimate goal of 
this study was to gain an improved understanding of the association between maternal nutritional 
status resulting from dietary insufficiency or imbalance of nutrients and potential risk for high 
prevalence of pregnancy complications. We proposed an integrated profiling strategy to 
quantitate a broad range of small-molecule metabolites and trace elements in pregnant women 
using immunoassay analyzer, gas chromatography time-of-flight mass spectrometry (GC–TOF 
MS), and inductive coupled plasma–mass spectrometry (ICP–MS). A comparative study was 
conducted on the pregnant women with normal pregnancies from two typical populations: one 
has the highest birth prevalence of congenital malformations in China while the other represents 
a national average level. Multivariate statistical technique was employed to afford a global view 
of similarities and separation trend of maternal nutritional status of the two populations. The fold 
changes and P values of the detected metabolites and trace elements were attained by Mann–
Whitney test. Correlation matrix map (CMM) and hierarchical cluster analysis (HCA) were 
performed to explore the interrelationship of metabolites and/or trace elements most correlated 
with the characteristic metabolic profile in Lvliang area.  
 
SUBJECTS AND METHODS 
Subjects, and inclusion/exclusion criteria  
Serum samples of pregnant women with normal pregnancy outcomes (n = 54) were collected 
from Lvliang prefecture of Shanxi province, a region with the highest prevalence of congenital 
malformations in China (Zheng et al. 2007). A comparative group of women with normal 
pregnancies (n = 40) was recruited from Huairou region of Beijing city that represents a national 
average prevalence of congenital malformations (Li et al. 2009). The basic characteristics and 
dietary information from all of the participants are provided in Table 1. 
 
 
Table 1: Descriptive characteristics of all of the subjects  
Groupsa  Descriptive statisticsb  Shanxi group Beijing group 
Maternal age (years) Mean (95% C.I.) 25.7 (24.6–26.9) 26.8 (25.3–28.0) 
Median (range) 25.0 (18–37) 26.0 (21–39) 
Gestational agec (weeks)  Mean (95% C.I.) 21.6 (19.5–23.6) 16.4 (14.4–18.4) 
Median (range) 20.0 (5–38) 15.5 (7–27) 
Total energy (kcal)   2414.3 2814.7 
Protein (g/day)   85.2 (12.1%) 94 (15.44%) 
Fat (g/day)   67.2 (20.8%) 83 (30.92%) 
Carbohydrates (g/day)   467.5 (67.1%) 324 (53.64%) 
aShanxi group (n = 54) and Beijing group (n = 40) are the groups of the pregnant women with normal pregnancies from Shanxi and from Beijing  
bMean (95% C.I.) is mean value of each group with 95% confidence interval (C.I.) and Median (range) is median value of each group with the 
range from minimum to maximum of the group  
cGestational age (weeks) was estimated starting either from the first day of the last woman’s last menstrual period or 14 days before conception 
(if the conception is known)  
 
 
The participants with normal pregnancy outcomes were confirmed by one-year follow-up 
examination using standard operational protocol (SOP) in our surveillance database developed 
jointly by Institute of Population Research/WHO Collaborating Center for Reproductive Health 
and Population Science at Peking University (Beijing, P. R. China). Subjects bearing diseases 
such as cardiovascular diseases, metabolic disorders (obesity, diabetes or diabetic 
complications), malignant tumors, taking anti-folate medication, or in influenza/inflammation 
with fever within 2 weeks before specimen collection were excluded. Blood sample collection, 
storage, and delivery were in compliance with SOP developed by Capital Institute of Pediatrics 
(CIP, Beijing, P. R. China) and implemented by the trained physicians or nurses at the both sites. 
The overnight (minimal 10 h to maximal 14 h) fasting blood sample was collected in the 
morning and placed in BD Vacutainer® Blood Collection Tubes (Franklin Lakes, NJ) at room 
temperature for 30 min allowing coagulation. The clotted blood samples were rimmed or ringed 
with an applicator stick if necessary, and centrifuged for 10 min at 3,000 rpm. Each 100 μl of 
supernatant fluid (serum) was aliquoted in 2 ml non-glass plastic Eppendorf centrifuge tube for 
multiple platform analysis and stored at −20°C until shipping. The samples were delivered to the 
research laboratory with dry ice and stored in −80°C freezer prior to sample preparation. The 
written informed consent and dietary questionnaires were gathered from each subject at the time 
of sampling. The study followed the Declaration of Helsinki and was approved by the 
Institutional Review Board at CIP.  
 
Immunoassay  
Folate (vitamin B9) and vitamin B12 are two fundamental nutrients for embryonic and fetal 
development, but they are not feasible for GC–TOF MS analysis due to their high polarity and 
molecular weight. We determined their concentrations in the two groups: Shanxi group (n = 54) 
and Beijing group (n = 40) using an immunoassay analyzer (IA) ARCHITECT i2000 (Abbott 
Laboratories Inc., Abbott Park, IL) following the manufacturer’s procedures (Abbott 2011).  
 
Untargeted profiling of small-molecule metabolites  
An unbiased metabolic profiling was performed by measuring a variety of small-molecule 
metabolites including amino acids, fatty acids, organic acids, carbohydrates etc. in serum from 
all of the participants. The sample preparation followed our previously published methods (Qiu 
et al. 2009; Wang et al. 2009). In brief, two internal standard solutions (10 μl of L-2-
chlorophenylalanine in water, 0.3 mg/ml; 10 μl of heptadecanoic acid in methanol, 1 mg/ml) 
were spiked with 100 μl of serum sample, to which 300 μl of organic mixture 
(methanol/chloroform = 3:1, v/v) was added for protein precipitation and small-molecule 
metabolite exaction. After vortexing and centrifugation, each aliquot of 300-μl supernatant was 
evaporated to dryness under vacuum at room temperature in a 2-ml sample vial. Subsequent to 
vacuum dryness, each 80 μl of methoxyamine (15 mg/ml in pyridine) was added to the vial and 
the reaction was maintained at 30°C for 90 min. The trimethylsilyl derivatization was conducted 
at 70°C for 60 min by the addition of 80 μl of N,O-bis(trimethylsilyl)-trifluoroacetamide 
(containing 1% trimethylchlorosilane). After centrifugation, each 1-μl aliquot of the supernatant 
was injected into a hyphenated Agilent 6890N gas chromatography (Agilent Technologies, Santa 
Clara, CA) coupled with a Pegasus HT time-of-flight mass spectrometer (Leco Corp., St Joseph, 
MI) in a splitless mode. To minimize systematic variations during sample analysis, the study 
samples were analyzed in the order of “Shanxi group subject 1 → Beijing group subject 
1 → Shanxi group subject 2…etc.” and the subject of each group was selected randomly. A DB-
5 ms capillary column (Dimension: 30 m × 250 μm I.D. 0.25 μm film thickness; Agilent J&W 
Scientific, Folsom, CA) was used for metabolite separation. The helium was used as carrier gas 
with a constant flow rate of 1.0 ml/min. The temperatures of the front inlet, transfer line, ion 
source, and quadruple were set to 270, 290, 200, and 150°C, respectively. The GC temperature 
program was set to 2 min isothermal heating at 80°C, followed by 10°C/min and oven 
temperature ramped to 180°C, 5°C/min to 240°C, and 25°C/min to 290°C, and a final 9 min 
maintaining at 290°C. Electron impact ionization at a full scan mode (m/z 30–600) was used with 
an acquisition rate of 20 spectra/sec.  
Quantification of minerals and trace elements  
A total of 16 macrominerals and trace elements including cobalt (Co), copper (Cu), zinc (Zn), 
selenium (Se), magnesium (Mg), phosphorus (P), chromium (Cr), arsenic (As), strontium (Sr), 
cadmium (Cd), tellurium (Te), barium (Ba), lead (Pb), tin (Sn), caesium (Cs), and erbium (Er) 
were quantitated using an Agilent 7500ce inductively coupled plasma–mass spectrometer (ICP–
MS, Agilent Tech., Tokyo, Japan) (Zhao et al. 2009). The serum samples were used from those 
subject (n = 19 per group) with sufficient volume of serum remained after GC–TOF MS and IA 
measurement. Each 0.1 g of serum sample was weighed and placed into a 15-ml PFA-coated 
pressure vessel, to which 150 μl of HNO3 (ultrapure grade, 65% v/v, Merck KGaA, Darmstadt, 
Germany) and 150 μl of H2O2 (ultrapure grade, 30% v/v, Merck KGaA, Darmstadt, Germany) 
were added. The digestion was carried out in a Mars-5 microwave digestion system (CEM Corp., 
Matthew, NC) with 40 reactors in a cycle using the following program: (i) 5 min at 1,600 W 
power and 115°C (ramp 10 min), (ii) 5 min at 1,600 W power and 150°C (ramp 4 min) and (iii) 
5 min at 1,600 W power and 185°C (ramp 4 min). The resulting solution was diluted into about 
1.3 g using 18.2 MΩ ultrapure water from Q-POD Element unit with LC-Pak filter (Millipore, 
Billerica, MA). The diluted samples were stored at 4°C refrigerator pending ICP–MS analysis. 
The internal standard solution was prepared by mixing the single-element standard solutions of 
Sc, In, and Re (Merck KGaA, Darmstadt, Germany) and introduced by peristaltic pump into ion 
source at an approximate concentration of 25 μg/l with an on-line mode. The instrument was 
tuned to an optimal condition across mass scan range using a tuning solution containing 10 μg/l 
Li, Y, Tl and Ce in 2% HNO3 (w/v) (Agilent Technologies, Tokyo, Japan). Data were acquired 
by Agilent Chemstation E.03.07 at a full-quantitation mode.  
 
Each of 16 single-element standard stock solutions at a concentration of 1,000 ppm (ultrapure 
grade, Alfa Aesar China, Beijing, P. R. China) was mixed and used for quantitation. The mixed 
solution of the 16 elements was diluted into a series of concentrations with 2% HNO3 to 
establish quantitation curves. The quantitative concentration range, linear equations, and 
coefficients of determination (R2) were attained by Agilent Chemstation software (Supplemental 
Table 1).  
 
Data pretreatment  
The raw data files from GC–TOF MS analysis were exported to NetCDF format by ChromaTOF 
software v4.40 (Leco Corp., St Joseph, MI) and processed by our previously developed software 
package in which automated peak detection, deconvolution, alignment, and library search were 
conducted (Jiang et al. 2010). The resulting data set was organized in a Microsoft Excel 
spreadsheet as a format of sample information (subject identity code), variable identities 
(retention time–unique mass pairs), and peak areas. Initial compound annotation was conducted 
by searching against commercial mass spectral databases such as NIST library 2008 (National 
Institute of Standards and Technology, Gaithersburg, MD) and LECO/Fiehn Metabolomics 
Library (Leco Corp., St Joseph, MI). Further validation of compound annotation was performed 
by comparing the mass spectral data and retention time of each tentatively assigned metabolite 
with those in our internal metabolite library encompassing over 500 endogenous metabolite 
standards commonly detected in biological matrix. The quantitative report of each sample 
generated from ICP–MS was stored as a separate csv format file by Agilent Chemstation 
E.03.07. In order to combine and compare the results from all of the files, the custom scripts 
compiled in MATLAB software (The MathWorks, Inc., Natick, MA) were used to extract 
information including sample information (subject identity code), variable identities (element 
symbols), and element concentrations. The exported data set was organized in a Microsoft Excel 
spreadsheet.  
 
Statistical analysis  
The metabolome data derived from both GC–TOF MS and IA was imported into SIMCA-P+ 
12.0.1 (Umetrics, Umeå, Sweden) for multivariate statistical analysis. To minimize statistical 
bias resulted from the concentration variations of different metabolites, the data set was mean-
centered and scaled to unit variance prior to principal component analysis (PCA) and partial least 
squares-discriminant analysis (PLS-DA) (Umetrics 2011; Wold 1987; Wold et al. 2001). 
Unsupervised PCA was performed to visualize intrinsic variations of nutritional status in 
pregnant women from the two regions at a global fashion. A more sophisticated discriminant 
technique PLS-DA was further applied to achieve global profile separation between inter-groups 
through maximizing systematic variations between the two groups. For PLS-DA modeling in 
SIMCA-P+ software, a default 7-fold (Leave–1/7th Samples–Out) cross–validation procedure 
was carried out to avoid model over-fitting (Trygg et al. 2007; Umetrics 2011). The values of the 
two key parameters, R2Y and Q2Y, approaching 1.0, imply a reliable mathematical model with 
satisfactory predictability, while the PLS-DA models with Q2Y value ≥0.40 are acceptable in 
practical applications (Trygg et al. 2007; Ni et al. 2008; Qiu et al. 2009).  
 
A non-parametric Mann–Whitney test in PASW Statistics 18.0 software package (The SPSS 
Inc., Chicago, IL) was used to determine if a significant difference of each metabolite or element 
exists between the Beijing group versus the Shanxi group. The critical P value was set as 0.05 in 
this study. The fold change (FC) was defined as the ratio of the mean rankings of metabolite 
signal response (peak areas) or trace element concentrations in the Shanxi group versus the 
Beijing group.  
 
With the aim of exploring the interrelationship of metabolites and/or trace elements potentially 
associated with pregnancy malnutrition status, CMM and HCA were employed in this study. 
HCA creates a hierarchy of clusters to measure the similarities and dissimilarities of the variables 
(herein referred to metabolites and/or elements) using a tree structure (dendrogram), in which the 
root of the tree consists of a single cluster containing all the variables and the leaves correspond 
to individual variable. CMM describes the interrelationship of these metabolites and/or elements 
using Pearson’s correlation coefficients. In CMM, each cell represents the correlation of the two 
given variables and the diagonal cells (correlations of variables with themselves) are always 
equal to 1.0. Both HCA and CMM were performed on R environment (R 2011).  
 
RESULTS 
Assessment of global metabolic profiles  
A three-dimensional (3D) PCA scores plot, which was constructed using a total of 343 
metabolite signals analyzed by GC–TOF MS and IA, depicted a clear separation trend of the 
global metabolic profiles between the Shanxi group and the Beijing group without any outliers 
detected (Fig. 1a). The metabolic profile variations between the two groups were further 
validated and presented by a three-component PLS-DA model with satisfactory modeling and 
predictive abilities (R2Y = 0.863 and Q2Y = 0.706) (Fig. 1b).  
 
Figure 1: Visualization of overall maternal nutritional status. a shows a 3-D PCA scores plot 
generated by a total of 343 metabolite signals analyzed by GC–TOF MS and IA. It presents a 
separation trend of maternal nutritional status in the pregnant women with normal pregnancies 
from Shanxi and Beijing regions. b A more intrinsic metabolic variation between the two groups 
was further validated and presented by a three-component PLS-DA model (R2Y = 0.863 and 
Q2Y = 0.706). In PCA and PLS-DA scores plot, each dot symbol represents an individual subject 
and the spatial distribution of these dots reveals the variations of maternal metabolic status  
 
 
 
Folate and vitamin B12  
According to the established criteria for nutritional disorders (serum folate <7 nmol/l and serum 
vitamin B12 < 145 pmol/l) (Johnson 2007), 22 subjects (40.7%) and 47 subjects (87.0%) in the 
Shanxi group were considered folate deficiency and vitamin B12 deficiency, respectively; 
whereas only three subjects (7.5%) and eight subjects (20%) in the Beijing group shown 
deficiency in the two nutrients, respectively. As illustrated in Figs. 2a, b, serum concentrations of 
folate and vitamin B12 were significantly lower (P < 0.001) in the Shanxi group than the Beijing 
group. The other noteworthy finding is that the serum concentrations of the two essential 
nutrients were consistently lower at each pregnancy trimester in the Shanxi group than in the 
Beijing group.  
 
Figure 2: Serum concentrations of representative metabolites. a – l show the concentrations of 
the representative metabolites that are most dysregulated in serum of the pregnant women from 
Shanxi group in comparison with that from the Beijing group. The dynamic metabolic variations 
are present at three different pregnancy trimesters, where the first, second, and third trimester are 
defined as the 0–13th week, 14th–26th week, and 27th–41st week of gestation, respectively. The 
bar is the median concentration of metabolites for each group and the error bar represents a 95% 
confidence interval (95% CI). The P values were obtained by Mann–Whitney test  
 
Metabolite analysis  
Using a threshold of P < 0.05 from Mann–Whitney test, we obtained a list of 51 differentially 
expressed metabolites in the Shanxi group in relative to the Beijing group (Supplemental 
Table 2). Kyoto Encyclopedia of Genes and Genomes (KEGG, www.genome.jp/kegg) pathway 
database and human metabolome database (HMDB, www.hmdb.ca) were employed to aid 
interpretation of pathophysiological molecular mechanisms by linking the differential 
metabolites with their biological function in metabolic regulatory network. As seen in Table 2, 
the representative metabolites were classified and sorted out by their regulatory pathways. In this 
study, significantly lower concentrations of carbohydrates and lipids while significantly higher 
concentrations of amino acids and urea-cycle metabolites were present in the Shanxi group in 
relative to the Beijing group. 
 
 
Table 2: A representative list of most dysregulated small-molecule metabolites between the 
normal pregnancy women from Shanxi versus those from Beijing  
Metabolitea  Metabolic pathway Shanxi versus Beijing 
FCb  P c  
Glucosed  Carbohydrates 0.71 4.61E−03 
Mannosed  Carbohydrates 0.63 5.84E−05 
Galactosed  Carbohydrates 0.67 8.77E−04 
Glucurono-6,3-lactone Carbohydrates 0.42 9.86E−13 
Sorbose Carbohydrates 0.59 4.14E−06 
Caproic acid Lipid metabolism 0.67 6.70E−04 
Dodecanoic acidd  Lipid metabolism 0.77 4.45E−02 
Stearic acidd  Lipid metabolism 0.77 2.62E−02 
Linoleic acidd  Lipid metabolism 0.71 7.25E−03 
Oleic acidd  Lipid metabolism 0.77 1.98E−02 
Petroselinic acidd  Lipid metabolism 0.71 5.51E−03 
Glyceraldehyded  Lipid metabolism 0.71 8.00E−03 
Glyceric acidd  Lipid metabolism 0.45 9.06E−11 
Cholesterold  Lipid metabolism 0.77 4.62E−02 
Phenylalanined  Amino acid 1.90 2.90E−06 
Leucined  Amino acid 1.40 1.07E−02 
Isoleucined  Amino acid 1.40 5.87E−03 
Prolined  Amino acid 1.60 3.29E−04 
Histidined  Amino acid 1.60 6.70E−04 
Serined  Amino acid/one carbon metabolism 2.00 6.54E−07 
Methionined  Amino acid/one carbon metabolism 1.90 4.67E−06 
Glycined  Amino acid/glutathione/one carbon metabolism 1.30 2.91E−02 
Cystined  Amino acid/glutathione/one carbon metabolism 0.67 8.51E−04 
Glutamic acidd  Amino acid/glutathione metabolism 2.10 6.26E−08 
Pyroglutamic acidd  Glutathione metabolism 1.50 1.36E−03 
Ornithined  Amino acid/urea cycle 2.20 2.84E−08 
Asparagined  Amino acid/urea cycle 2.00 7.12E−07 
Aspartic acidd  Amino acid/urea cycle 2.10 1.24E−07 
Citrullined  Amino acid/urea cycle 1.40 1.58E−02 
Uread  Urea cycle 1.50 4.05E−03 
Lactic acidd  Glycolysis 2.00 6.00E−07 
Uric acidd  Nuclear acid metabolism 0.63 2.10E−04 
Hypoxanthined  Nuclear acid metabolism 1.90 2.10E−06 
Dihydrouracild  Nuclear acid metabolism 1.80 1.78E−05 
aThese metabolites were annotated by NIST mass spectral database and selected for biological interpretation purpose. The complete list of 
differential metabolites is provided in Supplemental Table S2  
b Fold change (FC) was calculated by the ratio of mean rankings between two groups using Mann–Whitney test and the c P values were obtained 
accordingly. The critical P value was set as 0.05 across the study  
d These metabolites were validated by our metabolite library created by the standard compounds available  
 
 
 
 
Dynamic changes of metabolites during pregnancy trimesters  
As gestational age of the pregnant women at sampling could influence the maternal metabolic 
profiles, we investigated the serum metabolic variations across the three different pregnancy 
trimesters, where the first, second, and third trimester are defined as the 0–13th week, 14th–
26th week, and 27th–41st week of gestation, respectively (Zheng et al. 2011). As expected, the 
concentrations of the representative differential metabolites varied across the three different 
pregnancy trimesters but the change trend among the pregnancy trimesters was highly consistent 
(Fig. 2). For instance, the concentrations of vitamin B12, folate, sorbose, and γ-aminobutyric acid 
were lower in the Shanxi group at each pregnancy trimester than in the Beijing group while the 
concentrations of ornithine and asparagine were higher in the Shanxi group at all of the three 
pregnancy trimesters.  
 
Trace element quantitation  
Lower serum concentrations of Cu (FC = 0.77), Zn (FC = 0.80), Se (FC = 0.58), P (FC = 0.55), 
and Mg (FC = 0.77), while higher concentrations of Sr (FC = 1.41), Cd (FC = 1.25), and Pb 
(FC = 1.28), were observed in the Shanxi group than in the Beijing group (Fig. 3 and 
Supplemental Table 3).  
 
 
 
 
Figure 3: Serum concentrations of representative trace elements. a – h show the eight elements 
most dysregulated in serum of pregnant women from the Shanxi group in comparison with that 
from the Beijing group. The bar is the median concentration of trace elements for each group 
and the error bar represents a 95% CI. The P values were obtained by Mann–Whitney test  
 
 
 
Interrelationship of metabolites and/or elements  
A subset of 53 metabolites and 8 elements were selected for HCA and CMM analysis by P 
values and fold changes obtained from Mann–Whitney test. We conceived that these metabolites 
and elements were most correlated with the characteristic metabolic profile in Lvliang area. As 
seen in Fig. 4, certain essential nutrients such as folate, vitamin B12, Cu, Mg, and P are positively 
correlated with each other in CMM and they tend to cluster in HCA. This finding implicated that 
deficiency of certain nutrients may result in a synergistic impact on abnormal pregnancy 
outcomes. However, discussion of the intrinsic relation of metabolites and elements is beyond 
the scope of this study.  
 
 
 
Figure 4: Interrelationship of metabolites and/or elements using correlation matrix map (CMM) 
and hierarchical clustering analysis (HCA). This figure was produced by the 53 metabolites and 
8 elements most dysregulated in serum of pregnant women from Shanxi region versus that from 
Beijing region. The HCA uses average distance for clustering. In CMM, each cell represents a 
Pearson’s correlation coefficient that was calculated by each of two metabolites and/or elements. 
The negative values suggest an inverse correlation between the two given metabolites or 
elements while the positive values indicate a proportional relation between them  
 
 
DISCUSSION 
There is a considerable interest that maternal malnutrition can induce an impaired embryonic and 
fetal development, leading to ultimate impact on the fetus such as low birth weight, intrauterine 
growth restriction (IUGR), miscarriage, congenital malformations and so forth (CDC 1992; 
Gallou-Kabani and Junien 2005; Hadden and McLaughlin 2009; Harding 1999; Martin-Gronert 
and Ozanne 2006; McIntire et al. 1999; Wu et al. 2004). In this study, we profiled a broad range 
of small-molecule metabolites and trace elements in serum of pregnant women from two 
independent populations with high and average birth prevalence of congenital anomalies in 
offspring. In addition to severe deficiency of folate and vitamin B12, a distinct disturbance of 
many other essential small-molecule metabolites including carbohydrates, fatty acids, amino 
acids, intermediates of urea cycle, and certain trace elements was also recognized as an indicator 
of high prevalence of congenital malformations in Lvliang preference of Shanxi province.  
 
In this study, the significantly lower concentrations of folate (P < 0.001) and vitamin B12 
(P < 0.001) were observed in the pregnant women in the Shanxi group than in the Beijing group 
(Fig. 2a, b). Folate and vitamin B12 play crucial roles in DNA synthesis and regulation, rapid cell 
division, and one-carbon metabolism in biological system, thus these two vitamins are 
fundamental to fetal growth and development during pregnancy (Berry et al. 1999; De Wals et 
al. 2007; Mosley et al. 2009; Zheng et al. 2011; Zhu et al. 2009). In the case of the role of the 
two nutrients, our results implicated that deficiency in these two nutrients at early gestation stage 
and/or during pregnancy is potentially associated with abnormal pregnancy outcomes in 
offspring. This finding was also evidenced by the fact that there was significantly insufficient 
intake of dark green vegetables, fruits, meat, milk, and certain micronutrients including folic 
acid, zinc, selenium etc. in pregnant women from Lvliang area when compared with the national 
average level (Zhang et al. 2008).  
 
The most striking feature of this work is that we captured the characteristics of maternal 
metabolic phenotype during normal pregnancy in a region with the highest prevalence of 
congenital malformations in China, which is beyond a deficient status of folate and vitamin B12. 
In Fig. 1, both PCA and PLS-DA scores plots clearly demonstrated a distinct metabolic profile of 
pregnant women under malnutrition status in Shanxi area as compared to the Beijing group, 
although both of the two groups had normal pregnancy outcomes in offspring. Using Mann–
Whitney test with the threshold of P value less than 0.05, we obtained a list of 51 differentially 
expressed metabolites in the Shanxi group in relative to the Beijing group (Supplemental 
Table 2, 3). There is a significant decrease in carbohydrates including glucose, mannose, 
galactose, glucuronolactone etc. and seven fatty acids whereas a significant increase in 14 amino 
acids and intermediates of urea cycle such as ornithine, citrulline, and urea in the serum samples 
from the Shanxi group as compared to the pregnant women from Beijing. Pregnancy has a 
remarkable effect on the maternal metabolism and physiological state (Hadden and McLaughlin 
2009; Martin-Gronert and Ozanne 2006; King 2006). The concentrations of carbohydrates and 
lipids fluctuate substantially during pregnancy in order to maintain a continuous supply of 
nourishment for the growing fetus (Hadden and McLaughlin 2009; Martin-Gronert and Ozanne 
2006; King 2006). The significantly decreased concentrations of saccharides and lipids in 
maternal serum implicated either a reduced supply of these metabolites or an elevated 
consumption of them by fetal development process. From the dietary information present in 
Table 1, daily consumption of carbohydrates was markedly higher (about 44%) in the pregnant 
women from the Shanxi group than those from the Beijing group whereas fat intake per day was 
moderately lower (about 19%) in the Shanxi group than the Beijing group. Therefore, it is more 
likely that the significantly low concentration of maternal serum saccharides in the Shanxi group 
was resulted from an increased consumption of saccharides during fetal growth. However, it is 
difficult to determine which of these factors i.e., insufficient dietary fat supply or enhanced fat 
consumption by fetal growth and development, is dominant because they are highly interacted. 
Pregnant women normally sustain an elevated blood glucose level and undergo fat storage for 
fetal growth and development from their nongravid state and early pregnancy towards middle 
and late pregnancy (King 2006). The lower concentrations of saccharides and lipids in the 
Shanxi group suggested that their glucose metabolism and fat storage are suboptimal, which is 
detrimental to fetal development. In addition, as maternal saccharides and lipids are profoundly 
low, protein catabolism in maternal hepatic and adipose tissues will be activated to subsidize and 
preserve energy needs by fetus (Hadden and McLaughlin 2009; King 2006; Wu et al. 2004). As a 
consequence of protein catabolism, an increased concentration of amino acids was observed in 
maternal serum (Table 2). The enhanced amino acid oxidation could lead to an increased urea 
synthesis and urea nitrogen level in maternal blood and urine (Table 2). As urea concentration in 
maternal and fetal blood is nearly same through the exchange of urea in both of the circulations 
(Hutchinson et al. 1962), an unusual accumulation of maternal urea cycle metabolites due to 
pathophysiological change, may lead to an increase of these metabolites in fetal blood. 
Unfortunately, the significant elevation of urea excretion in a fetus causes chronic neurotoxicity 
to the fetus (Matsuoka and Igisu 1993). To this end, the disrupted energy supply from 
carbohydrate, lipid, and amino acid metabolism and subsequently urea over-excretion seem to be 
interrelated and present in pregnant women from a region with a high prevalence of severe 
congenital malformations. Additionally, we observed that several amino acids involved in one-
carbon metabolism, including serine, methionine and glycine were unexpectedly higher in serum 
of pregnant women from Lvliang region. We suspected that the synthesis from homocysteine to 
methionine was inhibited due to the depleted folate and vitamin B12 and as a consequence, one-
carbon metabolism donors including serine, methionine, and glycine in upstream can be 
excessive in serum samples from Lvliang region.  
 
Finally, we determined the concentrations of 16 representative elements in serum of the two 
groups of pregnant women. As illustrated in Fig. 3a–h, a relatively lower serum concentration of 
Se, Cu, Zn, Mg, and P while a higher concentration of Sr, Cd, and Pb were detected in the 
pregnant women from the Shanxi group, as compared to the subjects from the Beijing group. It is 
well-documented that essential trace elements e.g., selenium and copper play an indispensable 
role in various biological functions such as being a cofactor with enzymes in regulating cell 
signaling pathways (Rotruck et al. 1973). Trace element selenium is critical for cellular functions 
in most mammals and acts predominantly as a cofactor for the reduction of antioxidant enzymes 
such as glutathione peroxidases because it forms the bioactive center of certain enzymes 
(Rotruck et al. 1973). Essential element copper is often involved in maintaining the normal 
enzyme conformation of superoxide dismutase (SOD) and functions of the central nervous 
system (CNS). Thus, deficiency in these elements was linked with the occurrence or severity of 
congenital structural malformation in diverse human populations (Keen et al. 2003). 
Macrominerals such as cadmium and lead are believed to be teratogenic to normal biological 
system and exposure to those harmful elements during the embryonic developmental period will 
lead to an increased potential risk of congenital malformations (Ferm 1976, 1969).  
 
CONCLUDING REMARKS 
In our study, the pregnant women from Shanxi region demonstrated a multifaceted malnutrition 
status characterized by depleted serum concentrations of folate and vitamin B12, lower 
concentrations of Se, Zn, Cu, and higher concentrations of Sr, Cd, and Pb, significantly down-
regulated carbohydrate and lipid metabolism in combination with significantly increased amino 
acid and urea metabolism. The multiple metabolic variants as potential risk factors of congenital 
malformations suggest that malnutrition status in Shanxi area is multifaceted. Given the 
complexity of events that are required for impaired embryonic and fetal growth and 
development, it is very likely that congenital malformations result from disruptions in multiple 
developmental metabolic pathways. There is growing consensus that many metabolic 
dysregulations can be characterized by aberrant epigenetic programming that is associated with 
malnutrition-induced metabolic disturbances during fetal and postnatal development (Gallou-
Kabani and Junien 2005; Zeisel and da Costa 2009). DNA methylation patterns can be altered by 
many environmental factors including long-term malnutrition in prenatal or postnatal stages, and 
such epigenetic effects can be passed on to successive generations (Sinclair et al. 2007; Hanson 
and Gluckman 2008; Godfrey et al. 2011). We speculate that a significant disparity in the overall 
nutrition status in Shanxi group has modified one’s epigenetic marks, which may be an important 
mechanism for the high prevalence of phenotypic development of congenital anomalies in this 
region. If this hypothesis is true, our population-based prevention and improvement of prenatal 
congenital malformations should take into consideration two key components—a comprehensive 
dietary intervention to normalize multi-pathway metabolic dysregulations, and a long-term 
strategy to facilitate a gradual epigenetic normalization for fetal development, perhaps, through 
several generations.  
 
ACKNOWLEDGMENTS 
This work was finically supported by National Basic Research Program of China (also known as 
973 Program) (Grant No: 2007CB511901). The committee members of this program reviewed 
the outlines for the study and reviewed the results periodically, and oversee the progression of 
the program, but they were not involved in study design, sample collection, data analysis, and 
manuscript drafting and publication. All the authors reviewed and commented on the 
manuscript, and approved the submitted manuscript. 
 
CONFLICT OF INTEREST 
No potential conflict of interest relevant to this article was reported. 
 
 
REFERENCES 
Abbott (2011). ARCHITECT i2000 immunoassay analyzer 
http://www.abbottdiagnostics.com/Products/Instruments_by_Platform/?system=ARCHIT
ECT&suffix=i2000. Accessed October 11 2011.  
  
ACOG Practice Bulletin No. 58. Ultrasonography in pregnancy (2004). Obstetrics and 
Gynecology, 104(6), 1449–1458.  
  
Berry, R. J., Li, Z., Erickson, J. D., Li, S., Moore, C. A., Wang, H., et al. (1999). Prevention of 
neural-tube defects with folic acid in China. China–US collaborative project for neural 
tube defect prevention. New England Journal of Medicine, 341(20), 1485–1490. 
 
  
Brannon, P. M., & Picciano, M. F. (2011). Vitamin D in pregnancy and lactation in humans. 
Annual Review of Nutrition, 31, 89–115.  
 
Bucher, H. C., & Schmidt, J. G. (1993). Does routine ultrasound scanning improve outcome in 
pregnancy? Meta-analysis of various outcome measures. British Medical Journal, 
307(6895), 13–17. 
  
CDC. (1992). Recommendations for the use of folic acid to reduce the number of cases of spina 
bifida and other neural tube defects. Morbidity and mortality weekly report. 
Recommendations and Reports, 41(RR-14), 1–7.  
  
Christianson, A., Howson, C. P., & Modell, B. (2006). March of dimes global report of birth 
defects: The hidden toll of dying and disabled children. White Plains: March of Dimes 
Birth Defects Foundation.  
  
Crane, J. P., LeFevre, M. L., Winborn, R. C., Evans, J. K., Ewigman, B. G., Bain, R. P., et al. 
(1994). A randomized trial of prenatal ultrasonographic screening: impact on the 
detection, management, and outcome of anomalous fetuses. The RADIUS Study Group. 
American Journal of Obstetrics and Gynecology, 171(2), 392–399. 
  
De Wals, P., Tairou, F., Van Allen, M. I., Uh, S. H., Lowry, R. B., Sibbald, B., et al. (2007). 
Reduction in neural-tube defects after folic acid fortification in Canada. New England 
Journal of Medicine, 357(2), 135–142. 
  
Dunn, W. B., Brown, M., Worton, S. A., Crocker, I. P., Broadhurst, D., Horgan, R., et al. (2009). 
Changes in the metabolic footprint of placental explant-conditioned culture medium 
identifies metabolic disturbances related to hypoxia and pre-eclampsia. Placenta, 30(11), 
974–980. 
  
Ewigman, B. G., Crane, J. P., Frigoletto, F. D., LeFevre, M. L., Bain, R. P., & McNellis, D. 
(1993). Effect of prenatal ultrasound screening on perinatal outcome. RADIUS Study 
Group. New England Journal of Medicine, 329(12), 821–827. 
  
Ferm, V. H. (1969). The synteratogenic effect of lead and cadmium. Experientia, 25(1), 56–57. 
  
Ferm, V. H. (1976). Teratogenic effects and placental permeability of heavy metals. Current 
Topics in Pathology, 62, 145–151. 
  
Fiehn, O. (2002). Metabolomics—the link between genotypes and phenotypes. Plant Molecular 
Biology, 48(1–2), 155–171. 
  
Forchielli, M. L., McColl, R., Walker, W. A., & Lo, C. (1994). Children with congenital heart 
disease: A nutrition challenge. Nutrition Reviews, 52(10), 348–353. 
  
Gallou-Kabani, C., & Junien, C. (2005). Nutritional epigenomics of metabolic syndrome: New 
perspective against the epidemic. Diabetes, 54(7), 1899–1906. 
  
Godfrey, K. M., Inskip, H. M., & Hanson, M. A. (2011). The long-term effects of prenatal 
development on growth and metabolism. Seminars in Reproductive Medicine, 29(3), 
257–265. 
  
Hadden, D. R., & McLaughlin, C. (2009). Normal and abnormal maternal metabolism during 
pregnancy. Seminars in Fetal and Neonatal Medicine, 14(2), 66–71. 
  
Hanson, M. A., & Gluckman, P. D. (2008). Developmental origins of health and disease: New 
insights. Basic and Clinical Pharmacology and Toxicology, 102(2), 90–93. 
  
Harding, J. (1999). Nutritional causes of impaired fetal growth and their treatment. Journal of the 
Royal Society of Medicine, 92(12), 612–615. 
  
Harding, J. E., & Johnston, B. M. (1995). Nutrition and fetal growth. Reproduction, Fertility, 
and Development, 7(3), 539–547. 
  
Heazell, A. E., Brown, M., Dunn, W. B., Worton, S. A., Crocker, I. P., Baker, P. N., et al. 
(2008). Analysis of the metabolic footprint and tissue metabolome of placental villous 
explants cultured at different oxygen tensions reveals novel redox biomarkers. Placenta, 
29(8), 691–698. 
  
Horgan, R. P., Broadhurst, D. I., Dunn, W. B., Brown, M., Heazell, A. E., Kell, D. B., et al. 
(2010). Changes in the metabolic footprint of placental explant-conditioned medium 
cultured in different oxygen tensions from placentas of small for gestational age and 
normal pregnancies. Placenta, 31(10), 893–901. 
  
Hutchinson, D. L., Kelly, W. T., Friedman, E. A., & Plentl, A. A. (1962). The distribution and 
metabolism of carbon-labeled urea in pregnant primates. Journal of Clinical 
Investigation, 41, 1745–1753. 
  
Jiang, W., Qiu, Y., Ni, Y., Su, M., Jia, W., & Du, X. (2010). An automated data analysis pipeline 
for GC-TOF-MS metabonomics studies. Journal of Proteome Research, 9(11), 5974–
5981. 
  
Johnson, L. E. (2007). Vitamin deficiency, dependency, and toxicity. 
http://www.merckmanuals.com/professional/nutritional_disorders/vitamin_deficiency_de
pendency_and_toxicity/overview_of_vitamins.html. Accessed October 11 2011.  
  
Keen, C. L., Clegg, M. S., Hanna, L. A., Lanoue, L., Rogers, J. M., Daston, G. P., et al. (2003). 
The plausibility of micronutrient deficiencies being a significant contributing factor to the 
occurrence of pregnancy complications. Journal of Nutrition, 133(5 Suppl 2), 1597S–
1605S. 
  
Kenny, L. C., Broadhurst, D. I., Dunn, W., Brown, M., North, R. A., McCowan, L., et al. (2010). 
Robust early pregnancy prediction of later preeclampsia using metabolomic biomarkers. 
Hypertension, 56(4), 741–749. 
  
King, J. C. (2006). Maternal obesity, metabolism, and pregnancy outcomes. Annual Review of 
Nutrition, 26, 271–291. 
  
Klemmensen, A., Tabor, A., Osterdal, M. L., Knudsen, V. K., Halldorsson, T. I., Mikkelsen, T. 
B., et al. (2009). Intake of vitamin C and E in pregnancy and risk of pre-eclampsia: 
Prospective study among 57,346 women. BJOG, 116(7), 964–974. 
 
Koury, M. J., & Ponka, P. (2004). New insights into erythropoiesis: The roles of folate, vitamin 
B12, and iron. Annual Review of Nutrition, 24, 105–131. 
  
Leffelaar, E. R., Vrijkotte, T. G., & van Eijsden, M. (2010). Maternal early pregnancy vitamin D 
status in relation to fetal and neonatal growth: Results of the multi-ethnic Amsterdam 
born children and their development cohort. British Journal of Nutrition, 104(1), 108–
117. 
  
Li, Y., Liu, X. H., Wang, F. Y., Zhao, X. L., Zhang, X., & Zhang, Y. P. (2009). Analysis of the 
birth defects among 61 272 live born infants in Beijing. Journal of Peking University 
Health Sciences, 41(4), 414–417. 
  
Martin, J. A., Kung, H. C., Mathews, T. J., Hoyert, D. L., Strobino, D. M., Guyer, B., et al. 
(2008). Annual summary of vital statistics: 2006. Pediatrics, 121(4), 788–801. 
  
Martin-Gronert, M. S., & Ozanne, S. E. (2006). Maternal nutrition during pregnancy and health 
of the offspring. Biochemical Society Transactions, 34(Pt 5), 779–782. 
  
Matsuoka, M., & Igisu, H. (1993). Comparison of the effects of L-carnitine, D-carnitine and 
acetyl-L-carnitine on the neurotoxicity of ammonia. Biochemical Pharmacology, 46(1), 
159–164. 
  
McCance, D. R., Holmes, V. A., Maresh, M. J., Patterson, C. C., Walker, J. D., Pearson, D. W., 
et al. (2010). Vitamins C and E for prevention of pre-eclampsia in women with type 1 
diabetes (DAPIT): A randomised placebo-controlled trial. Lancet, 376(9737), 259–266. 
  
McIntire, D. D., Bloom, S. L., Casey, B. M., & Leveno, K. J. (1999). Birth weight in relation to 
morbidity and mortality among newborn infants. New England Journal of Medicine, 
340(16), 1234–1238. 
  
Mosley, B. S., Cleves, M. A., Siega-Riz, A. M., Shaw, G. M., Canfield, M. A., Waller, D. K., et 
al. (2009). Neural tube defects and maternal folate intake among pregnancies conceived 
after folic acid fortification in the United States. American Journal of Epidemiology, 
169(1), 9–17. 
  
Ni, Y., Su, M., Lin, J., Wang, X., Qiu, Y., Zhao, A., et al. (2008). Metabolic profiling reveals 
disorder of amino acid metabolism in four brain regions from a rat model of chronic 
unpredictable mild stress. FEBS Letters, 582(17), 2627–2636. 
  
Nicholson, J. K., Lindon, J. C., & Holmes, E. (1999). ‘Metabonomics’: Understanding the 
metabolic responses of living systems to pathophysiological stimuli via multivariate 
statistical analysis of biological NMR spectroscopic data. Xenobiotica, 29(11), 1181–
1189. 
  
Odibo, A. O., Goetzinger, K. R., Odibo, L., Cahill, A. G., Macones, G. A., Nelson, D. M., et al. 
(2011). First-trimester prediction of preeclampsia using metabolomic biomarkers: A 
discovery phase study. Prenatal Diagnosis, 31(10), 990–994. 
  
Polyzos, N. P., Mauri, D., Tsappi, M., Tzioras, S., Kamposioras, K., Cortinovis, I., et al. (2007). 
Combined vitamin C and E supplementation during pregnancy for preeclampsia 
prevention: A systematic review. Obstetrical and Gynecological Survey, 62(3), 202–206. 
  
Qiu, Y., Cai, G., Su, M., Chen, T., Zheng, X., Xu, Y., et al. (2009). Serum metabolite profiling of 
human colorectal cancer using GC-TOFMS and UPLC-QTOFMS. Journal of Proteome 
Research, 8(10), 4844–4850. 
  
R (2011). The R project for statistical computing. Accessed October 11 2011.  
  
Robinson, C. J., Wagner, C. L., Hollis, B. W., Baatz, J. E., & Johnson, D. D. (2011). Maternal 
vitamin D and fetal growth in early-onset severe preeclampsia. American Journal of 
Obstetrics and Gynecology, 204(6), 556.e1–556.e4.  
  
Rotruck, J. T., Pope, A. L., Ganther, H. E., Swanson, A. B., Hafeman, D. G., & Hoekstra, W. G. 
(1973). Selenium: Biochemical role as a component of glutathione peroxidase. Science, 
179(73), 588–590. 
  
Rynn, L., Cragan, J., & Correa, A. (2008). Update on overall prevalence of major birth defects—
Atlanta, Georgia, 1978–2005. Morbidity and Mortality Weekly Report, 57(1), 1–5.  
  
Shen, Q., Li, X., Qiu, Y., Su, M., Liu, Y., Li, H., et al. (2008). Metabonomic and metallomic 
profiling in the amniotic fluid of malnourished pregnant rats. Journal of Proteome 
Research, 7(5), 2151–2157. 
  
Sinclair, K. D., Lea, R. G., Rees, W. D., & Young, L. E. (2007). The developmental origins of 
health and disease: Current theories and epigenetic mechanisms. Society of Reproduction 
and Fertility Supplement, 64, 425–443. 
  
Steegers-Theunissen, R. P. (1995). Folate metabolism and neural tube defects: A review. 
European Journal of Obstetrics, Gynecology, and Reproductive Biology, 61(1), 39–48. 
  
Tissot van Patot, M. C., Murray, A. J., Beckey, V., Cindrova-Davies, T., Johns, J., Zwerdlinger, 
L., et al. (2010). Human placental metabolic adaptation to chronic hypoxia, high altitude: 
Hypoxic preconditioning. American Journal of Physiology Regulatory Integrative and 
Comparative Physiology, 298(1), R166–R172. 
  
Trygg, J., Holmes, E., & Lundstedt, T. (2007). Chemometrics in metabonomics. Journal of 
Proteome Research, 6(2), 469–479. 
  
Turner, E., Brewster, J. A., Simpson, N. A., Walker, J. J., & Fisher, J. (2007). Plasma from 
women with preeclampsia has a low lipid and ketone body content—A nuclear magnetic 
resonance study. Hypertension in Pregnancy, 26(3), 329–342. 
  
Umetrics (2011). SIMCA-P+. http://www.umetrics.com/simca. Accessed October 11 2011.  
  
Wang, X., Zhao, T., Qiu, Y., Su, M., Jiang, T., Zhou, M., et al. (2009). Metabonomics approach 
to understanding acute and chronic stress in rat models. Journal of Proteome Research, 
8(5), 2511–2518. 
  
Wold, S. (1987). Principal component analysis. Chemometrics and Intelligent Laboratory 
Systems, 2(1), 37–52. 
  
Wold, S., Trygg, J., Berglund, A., & Antti, H. (2001). Some recent developments in PLS 
modeling. Chemometrics and Intelligent Laboratory Systems, 58(2), 131–150. 
  
Wu, G., Bazer, F. W., Cudd, T. A., Meininger, C. J., & Spencer, T. E. (2004). Maternal nutrition 
and fetal development. Journal of Nutrition, 134(9), 2169–2172. 
  
Xia, H., Chi, Y., Qi, X., Su, M., Cao, Y., Song, P., et al. (2011). Metabolomic evaluation of di-n-
butyl phthalate-induced teratogenesis in mice. Metabolomics, 7(4), 559–571.  
  
Zeisel, S. H., & da Costa, K. A. (2009). Choline: An essential nutrient for public health. 
Nutrition Reviews, 67(11), 615–623. 
  
Zhang, B. Y., Zhang, T., Lin, L. M., Wang, F., Xin, R. L., Gu, X., et al. (2008). Correlation 
between birth defects and dietary nutrition status in a high incidence area of China. 
Biomedical and Environmental Sciences, 21(1), 37–44. 
  
Zhao, T., Chen, T., Qiu, Y., Zou, X., Li, X., Su, M., et al. (2009). Trace element profiling using 
inductively coupled plasma mass spectrometry and its application in an osteoarthritis 
study. Analytical Chemistry, 81(9), 3683–3692. 
  
Zheng, X. Y., Song, X. M., Chen, G., Chen, J. P., Ji, Y., Wu, J. L., et al. (2007). Epidemiology of 
birth defects in high-prevalence areas of China. Zhonghua Liu Xing Bing Xue Za Zhi, 
28(1), 5–9. 
  
Zheng, X., Su, M., Pei, L., Zhang, T., Ma, X., Qiu, Y., et al. (2011). Metabolic signature of 
pregnant women with neural tube defects in offspring. Journal of Proteome Research, 
10(10), 4845–4854. 
  
Zhu, H., Kartiko, S., & Finnell, R. H. (2009). Importance of gene-environment interactions in the 
etiology of selected birth defects. Clinical Genetics, 75(5), 409–423. 
 
